# THALGO BB Cream Illuminating Multi Perfection 40ml — Correttori [Source]() Language: it\-it Model: THBB1 Brand: Thalgo [Image]() ## Description THALGO BB Cream Illuminating Multi Perfection 40ml — Correttori Questo prodotto appartiene alla categoria “Correttori” ed è del marchio Thalgo\. Prima dell’acquisto e dell’uso\, verificare ingredienti\, modalità d’uso e avvertenze del produttore\. Descrizione originale dettagliata \(inglese\) A blend of 24H hydration\, marine \"airbrush effect\" particles and a BB Cream\, this hybrid product\, created exclusively by THALGO\, reveals blemish\-free skin\: Sève Bleue des Océans fills the skin with water while algae sugars smooth the skin\'s micro\-relief\, allowing the radiance\-boosting pigments to even and enhance the complexion\. RESULTS 24H Hydration Refined skin texture Evened and illuminated complexion Blurred skin imperfections UVA\/UVB protection \- SPF15 Apply from the centre of the face outwards\. Remove make\-up at the end of the day\. REASONS WHY YOU\'LL LOVE IT\, JUST LIKE 9 IN 10 WOMEN \(3\) • 24H skin hydration \(1\) • Suitable for all skin types \(2\-3\) • Non\-comedogenic and non\-acnegenic \(4\) • Lasts all day\, without the need for touch\-ups \(3\) • Protects the skin from sun damage • Improves the quality of the skin in 4 weeks \(3\) \(1\) Cornemetric assessment of the hydrating effectiveness following one standardised application of the product on 11 volunteers\. \(2\-3\) Clinical study under dermatologist supervision on 33 volunteers \(23\-54 years of age\; all skin types\) before use of the Illuminating Multi\-Perfection BB Cream \- Golden Self\-assessment\. \% of volunteers in agreement with the claim\. \(2\) From the first application\. \(3\) After 28 days of use\. \(4\) Clinical study under dermatologist supervision on 16 volunteers \(24\-39 years of age\) presenting combination to oily skin\, having used the Illuminating Multi\-Perfection BB Cream \- Golden for 28 days\. Assessment of the comedogenic and acnegenic potential by counting retentional lesions and inflammatory lesoins\, respectively\.